Action of the SV40 T Antigen Chaperone Machine on Tumor Suppressors
SV40 T 抗原伴侣机对肿瘤抑制剂的作用
基本信息
- 批准号:7223496
- 负责人:
- 金额:$ 30.48万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-04-14 至 2011-02-28
- 项目状态:已结题
- 来源:
- 关键词:ATP HydrolysisATP phosphohydrolaseAdoptedAmino AcidsApoptosisBindingBiochemicalBiochemical GeneticsBiologicalCell Cycle RegulationCell ProliferationCell physiologyChemicalsChromatinComplexCrystallizationCrystallographyDNA biosynthesisDataDevelopmentDiscriminationDiseaseDisruptionE2F transcription factorsElevationFamilyFamily memberGene MutationGenesGeneticGenetic TranscriptionGoalsGrowthHomeostasisHomologous GeneHost DefenseIn VitroInfectionLocalizedLocationMalignant NeoplasmsMediatingModelingMolecularMolecular ChaperonesMolecular ConformationOncogene ProteinsParticipantPhosphorylationPlayPliabilityProductionProtein BindingProteinsRBL2 geneReactionRecruitment ActivityRegulationRelaxationResolutionRestRetinoblastomaRetinoblastoma ProteinRoleSignal TransductionSimian virus 40StagingSystemTestingTissuesTranscriptional ActivationTranscriptional RegulationTumor AntigensTumor Suppressor ProteinsViralViral Tumor AntigensVirionVirusVirus DiseasesWorkX-Ray Crystallographyantigen bindingbasegenetic regulatory proteinhuman RBL2 proteinin vivointerestmembermetaplastic cell transformationmutantpromoterresearch studysialosyl-T antigenthree dimensional structuretranscription factor
项目摘要
DESCRIPTION (provided by applicant): Tumor suppressors are regulatory proteins that receive and integrate diverse signals and function to exert control over key cellular processes such as cell proliferation, differentiation, and apoptosis. Because loss or perturbation of their activity often results in cancer or other diseases, and because of their central role in governing organismal development and tissue homeostasis, these proteins are of great interest. The retinoblastoma protein (pRb) is a well characterized tumor suppressor that, in concert with two related proteins, p130 and p107, control cell cycle entry and exit, in part, by regulating the activity of the E2F family of transcription factors. Many viruses, including Simian virus 40 (SV40) encode oncoproteins that bind Rb-family members and interfere with their ability to regulate E2Fs. The large tumor antigen (T antigen) encoded by SV40 binds to pRb, p107, and p130 via an LXCXE motif and blocks the ability of these proteins to inhibit E2F-dependent transcription and to induce growth arrest. The retinoblastoma family has been studied intensively, yet little is known about the molecular basis by which viruses, such as SV40, block their action. In fact, interaction with T antigen has different consequences for each Rb protein. For example, p130 is degraded following SV40 infection or transformation, while the levels of pRb remain unchanged. Thus, T antigen appears to be able to distinguish different Rb-E2F complexes, but the basis for this discrimination is unknown. Like many regulatory proteins pRb and E2F transcription factors do not exist in isolation. Rather they function as part of large multiprotein assemblages that include chromatin modifiers, the basal transcription apparatus, as well as other factors, and the dynamic assembly and disassembly of these complexes is critical to their regulation. T antigen has a J domain and has been shown to function as a DnaJ molecular chaperone. The J domain is required for a vital DNA replication, transcriptional control, and virion assembly. Importantly, the J domain is required for T antigen to block the function of Rb proteins and thus to activate E2F-dependent transcription. This application seeks to understand the mechanistic and structural basis for the action of T antigen's recognition and disruption of Rb-E2F complexes. First, biochemical studies will explore the ability of the T antigen chaperone machine to distinguish and act upon p130-E2F4-DP1, pRb-E2F4-DP1, and pRb-E2F1-DP1 complexes. Second, the role of J domain orientation and flexibility will be examined using a combination of NMR and X-ray crystallography. Finally, a combined genetic and biochemical approach will be used to identify additional protein participants in the chaperone reaction. These studies will enhance our understanding of how these tumor suppressors govern cell proliferation and survival, and how subversion of these mechanisms by viruses or genetic mutation, contribute to cancer.
描述(由申请人提供):肿瘤抑制因子是一种调节蛋白,可接收和整合多种信号,并发挥作用以控制关键细胞过程,如细胞增殖、分化和凋亡。由于其活性的丧失或干扰通常会导致癌症或其他疾病,并且由于其在控制生物体发育和组织稳态中的核心作用,这些蛋白质引起了极大的兴趣。视网膜母细胞瘤蛋白(pRb)是一种特征明确的肿瘤抑制因子,与两种相关蛋白p130和p107一起,部分通过调节E2 F家族转录因子的活性来控制细胞周期的进入和退出。许多病毒,包括猿猴病毒40(SV 40)编码的癌蛋白结合Rb家族成员,并干扰他们的能力,调节E2 Fs。由SV 40编码的大肿瘤抗原(T抗原)通过LXCXE基序与pRb、p107和p130结合,并阻断这些蛋白抑制E2 F依赖性转录和诱导生长停滞的能力。视网膜母细胞瘤家族已被深入研究,但对病毒(如SV 40)阻断其作用的分子基础知之甚少。事实上,与T抗原的相互作用对每个Rb蛋白具有不同的结果。例如,p130在SV 40感染或转化后降解,而pRb的水平保持不变。因此,T抗原似乎能够区分不同的Rb-E2 F复合物,但这种区分的基础是未知的。与许多调节蛋白一样,pRb和E2 F转录因子并不孤立存在。相反,它们作为大型多蛋白组装的一部分发挥作用,包括染色质修饰剂,基础转录装置以及其他因子,这些复合物的动态组装和拆卸对其调控至关重要。T抗原具有J结构域,并已显示作为DnaJ分子伴侣发挥作用。J结构域对于重要的DNA复制、转录控制和病毒体组装是必需的。重要的是,J结构域是T抗原阻断Rb蛋白功能所必需的,从而激活E2 F依赖性转录。本申请试图理解T抗原识别和破坏Rb-E2 F复合物的作用的机制和结构基础。首先,生物化学研究将探索T抗原伴侣机器区分和作用于p130-E2 F4-DP 1、pRb-E2 F4-DP 1和pRb-E2 F1-DP 1复合物的能力。其次,J域的方向和灵活性的作用将使用NMR和X射线晶体学的组合进行检查。最后,一个组合的遗传和生物化学方法将被用来确定其他蛋白质参与分子伴侣反应。这些研究将增强我们对这些肿瘤抑制因子如何控制细胞增殖和存活的理解,以及病毒或基因突变如何颠覆这些机制,从而导致癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES M PIPAS其他文献
JAMES M PIPAS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES M PIPAS', 18)}}的其他基金
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10401454 - 财政年份:2020
- 资助金额:
$ 30.48万 - 项目类别:
Analysis of cellular factors limiting productive JC virus infections
限制生产性 JC 病毒感染的细胞因素分析
- 批准号:
10312804 - 财政年份:2020
- 资助金额:
$ 30.48万 - 项目类别:
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10030247 - 财政年份:2020
- 资助金额:
$ 30.48万 - 项目类别:
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10196991 - 财政年份:2020
- 资助金额:
$ 30.48万 - 项目类别:
Manipulation of innate immunity by Polyomavirus T antigens
多瘤病毒 T 抗原操纵先天免疫
- 批准号:
10621762 - 财政年份:2020
- 资助金额:
$ 30.48万 - 项目类别:
Exploring viral infection with single cell transcriptomics
用单细胞转录组学探索病毒感染
- 批准号:
9285734 - 财政年份:2016
- 资助金额:
$ 30.48万 - 项目类别:
Regulation of cellular functions by two human Polyomaviruses
两种人类多瘤病毒对细胞功能的调节
- 批准号:
9088664 - 财政年份:2016
- 资助金额:
$ 30.48万 - 项目类别:
Exploring viral infection with single cell transcriptomics
用单细胞转录组学探索病毒感染
- 批准号:
9167182 - 财政年份:2016
- 资助金额:
$ 30.48万 - 项目类别:
Regulation of Transcription and Translation by Human Polyomaviruses
人类多瘤病毒的转录和翻译调控
- 批准号:
8849838 - 财政年份:2014
- 资助金额:
$ 30.48万 - 项目类别:
Regulation of Transcription and Translation by Human Polyomaviruses
人类多瘤病毒的转录和翻译调控
- 批准号:
8768850 - 财政年份:2014
- 资助金额:
$ 30.48万 - 项目类别: